Standardized Protocol Alters Medication Use in Pediatric Cannabis Hyperemesis Syndrome

Cannabis hyperemesis syndrome has emerged as a significant challenge in emergency medicine, characterized by cyclical episodes of intractable nausea and vomiting in chronic users that frequently resist conventional antiemetic therapy [1]. The condition often necessitates specialized interventions such as topical capsaicin or antipsychotics, yet these treatments require careful navigation of risks including electrolyte imbalances and QTc prolongation, a delay in cardiac repolarization that can predispose patients to dangerous arrhythmias [2, 3]. Because these patients often present with high healthcare utilization and frequent return visits, establishing consistent diagnostic and treatment frameworks is essential for optimizing acute care [4]. Current guidelines emphasize the need for nonjudgmental, evidence-based protocols to abort acute episodes and reduce the burden on emergency resources [3]. A recent study evaluated how the formal implementation of a standardized management algorithm influenced prescribing habits and patient outcomes in a pediatric emergency department.